Suppression of microRNAs by dual-targeting and clustered Tough Decoy inhibitors

RNA Biology

Volumn 10, Issue 3, 2013, Pages 406-414

  Hollensen, Anne Kruse ^a   Bak, Rasmus O ^a   Haslund, Didde ^a   Mikkelsen, Jacob Giehm ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

microRNA inhibition; miRNA; Post transcriptional gene regulation; Tough Decoy; TuD

Indexed keywords

AGENTS AFFECTING NUCLEIC ACID METABOLISM; FIREFLY LUCIFERASE; MICRORNA; MICRORNA 143; MICRORNA 145; MICRORNA 146A; MICRORNA 16; MICRORNA 222; MIRNA 195; MIRNA 203; NUCLEOTIDYLTRANSFERASE INHIBITOR; PLASMID DNA; RENILLA LUCIFERIN 2 MONOOXYGENASE; SHORT HAIRPIN RNA; TOUGH DECOY MICRORNA INHIBITOR; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DESIGN; DRUG TARGETING; EXPERIMENTAL DESIGN; EXPRESSION VECTOR; GENE REPRESSION; GENETIC TRANSFECTION; HUMAN; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PLASMID; REPORTER GENE;

MICRORNA INHIBITION; MIRNA; POST-TRANSCRIPTIONAL GENE REGULATION; TOUGH DECOY; TUD;

BINDING SITES; GENE EXPRESSION REGULATION; GENETIC VECTORS; HEK293 CELLS; HUMANS; MICRORNAS; RNA POLYMERASE II; RNA, SMALL INTERFERING;

EID: 84874965759     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.23543     Document Type: Article

References (22)

1. Bartel D P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-97; PMID:14744438; http://dx.doi.org/10.1016/S0092-8674(04) 00045-5.
2. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435:834-8; PMID:15944708; http://dx.doi.org/10.1038/nature03702.
3. McDermott AM, Heneghan HM, Miller N, Kerin MJ. The therapeutic potential of microRNAs: disease modulators and drug targets. Pharm Res 2011; 28:3016-29; PMID:21818713; http://dx.doi.org/10.1007/s11095-011-0550-2.
4. Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005; 438:685-9; PMID:16258535; http://dx.doi.org/10.1038/nature04303.
5. Kay MA. State-of-the-art gene-based therapies: the road ahead. Nat Rev Genet 2011; 12:316-28; PMID:21468099; http://dx.doi.org/10.1038/nrg2971.
6. Scherr M, Venturini L, Battmer K, Schaller-Schoenitz M, Schaefer D, Dallmann I, et al. Lentivirus-mediated antagomir expression for specific inhibition of miRNA function. Nucleic Acids Res 2007; 35:e149; PMID:18025036; http://dx.doi.org/10.1093/nar/gkm971.
7. Primo MN, Bak RO, Schibler B, Mikkelsen JG. Regulation of pro-inflammatory cytokines TNF α and IL24 by microRNA-203 in primary keratinocytes. Cytokine 2012; 60:741-8; PMID:22917968; http://dx.doi.org/10. 1016/j.cyto.2012.07.031.
8. Gentner B, Schira G, Giustacchini A, Amendola M, Brown BD, Ponzoni M, et al. Stable knockdown of microRNA in vivo by lentiviral vectors. Nat Methods 2009; 6:63-6; PMID:19043411; http://dx.doi.org/10.1038/nmeth.1277.
9. Haraguchi T, Ozaki Y, Iba H. Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells. Nucleic Acids Res 2009; 37:e43; PMID:19223327; http://dx.doi.org/10.1093/ nar/gkp040.
10. Bak RO, Hollensen AK, Primo MN, Sørensen CD, Mikkelsen JG. Potent microRNA suppression by RNA Pol II-transcribed 'Tough Decoy' inhibitors. [Epub ahead of print]. RNA 2012; PMID:23249752; http://dx.doi.org/10.1261/rna.034850. 112.
11. Haraguchi T, Nakano H, Tagawa T, Ohki T, Ueno Y, Yoshida T, et al. A potent 2'-O-methylated RNA-based microRNA inhibitor with unique secondary structures. Nucleic Acids Res 2012; 40:e58; PMID:22259037; http://dx.doi.org/10. 1093/nar/gkr1317.
12. Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 2007; 4:721-6; PMID:17694064; http://dx.doi.org/10.1038/nmeth1079.
13. Kluiver J, Gibcus JH, Hettinga C, Adema A, Richter MK, Halsema N, et al. Rapid generation of microR-NA sponges for microRNA inhibition. PLoS One 2012; 7:e29275; PMID:22238599; http://dx.doi.org/10.1371/journal.pone.0029275.
14. Sato K, Hamada M, Asai K, Mituyama T. CENTROIDFOLD: a web server for RNA secondary structure prediction. Nucleic Acids Res 2009; 37(Web Server issue):W277-80; PMID:19435882; http://dx.doi.org/10.1093/nar/gkp367.
15. Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010; 327:198-201; PMID:19965718; http://dx.doi.org/10.1126/sci-ence.1178178.
16. Wahid F, Shehzad A, Khan T, Kim YY. MicroRNAs: synthesis, mechanism, function, and recent clinical trials. Biochim Biophys Acta 2010; 1803:1231-43; PMID:20619301; http://dx.doi.org/10.1016/j.bbam-cr.2010.06.013.
17. Medina P P, Slack FJ. Inhibiting microRNA function in vivo. Nat Methods 2009; 6:37-8; PMID:19116612; http://dx.doi.org/10.1038/nmeth0109-37.
18. Mikkelsen JG, Pedersen FS. Genetic reassortment and patch repair by recombination in retroviruses. J Biomed Sci 2000; 7:77-99; PMID:10754383; http://dx.doi.org/10.1007/BF02256615.
19. Westerhout EM, Berkhout B. A systematic analysis of the effect of target RNA structure on RNA interference. Nucleic Acids Res 2007; 35:4322-30; PMID:17576691; http://dx.doi.org/10.1093/nar/gkm437.
20. Bak RO, Stenderup K, Rosada C, Petersen LB, Moldt B, Dagnæs-Hansen F, et al. Targeting of human interleukin-12B by small hairpin RNAs in xeno-grafted psoriatic skin. BMC Dermatol 2011; 11:5; PMID:21352568; http://dx.doi.org/10.1186/1471-5945-11-5.
21. Jakobsen M, Stenderup K, Rosada C, Moldt B, Kamp S, Dam TN, et al. Amelioration of psoriasis by anti-TNF-alpha RNAi in the xenograft transplantation model. Mol Ther 2009; 17:1743-53; PMID:19568223; http://dx.doi.org/10.1038/mt.2009.141.
22. Staunstrup NH, Madsen J, Primo MN, Li J, Liu Y, Kragh PM, et al. Development of transgenic cloned pig models of skin inflammation by DNA transposon-directed ectopic expression of human β1 and α2 inte-grin. PLoS One 2012; 7:e36658; PMID:22590584; http://dx.doi.org/10.1371/journal.pone. 0036658.